PAPER Huang YQ, Liu XG, Zhang L, Yu Y, Xue J, Sun JL

[Effect of mammalian target of rapamycin on cognitive dysfunction of Alzheimer's Disease via regulating Homer3].

Zhonghua Yi Xue Za Zhi. 2020 May 5;100(17):1336-1340. PubMed.

PAPER Wang LJ, He JC, Wang LF, Gu YW, Fan HG, Tian HJ

[Neuroprotective effect of ginsenoside Rb-1 on a rat model of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2020 Aug 18;100(31):2462-2466. PubMed.

PAPER Chen HM, Zhang MM, Wang YL

[Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].

Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3397-3401. PubMed.

PAPER Liu J, Cao ZY

[Roles of amyloid-β in the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease should be clarified].

Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3385-3387. PubMed.

PAPER Chen JY, Liu XY, Xu YS, Fan DS

[Association between rare UBQLN2 variants and amyotrophic lateral sclerosis in Chinese population].

Zhonghua Yi Xue Za Zhi. 2021 Mar 30;101(12):846-850. PubMed.

PAPER Li LJ, Yang J, Yuan YP, Wang YY, Liu XJ, Jiang CY, Xu YM

[Application of skin phosphorylated synuclein in the diagnosis of dementia with Lewy body].

Zhonghua Yi Xue Za Zhi. 2022 Feb 8;102(5):378-381. PubMed.

PAPER Zhang YY, Xin X, Yang CY, Wang XY, Xia T, Wang HY

[The application value of plasma heterogeneous nuclear ribonucleoprotein A2/B1, Aβ42 and P-tau in the preoperative diagnosis of mild cognitive dysfunction].

Zhonghua Yi Xue Za Zhi. 2022 Feb 8;102(5):321-325. PubMed.

PAPER Liu SW, Xie WY, Zhang YC, Zhu JT, Liu CF, Hu H

[Third ventricle width measured by transcranial ultrasound and its diagnostic value in patients with Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2022 Apr 5;102(13):948-953. PubMed.

PAPER Liu SW, Li M, Zhu JT, Zhang YC, Wu YH, Liu CF, Hu H

[Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2022 Sep 20;102(35):2786-2792. PubMed.

PAPER Yan XM, Li PJ, Li W, Wang XM, Yu S

[Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].

Zhonghua Yi Xue Za Zhi. 2023 Oct 10;103(37):2933-2939. PubMed.

PAPER Li XG, Liu MS, Cui LY

[Attention should be paid to the importance of genetic testing in clinical practice of amyotrophic lateral sclerosis].

Zhonghua Yi Xue Za Zhi. 2023 Oct 24;103(39):3071-3076. PubMed.

PAPER Gu Q, Chen SF, Chen KL, Huang YY, Ge JJ, Zuo CT, Cui M, Dong Q, Yu JT

[The clinical application value of brain 18F-FDG PET/CT in the diagnostics of Parkinsonian syndromes].

Zhonghua Yi Xue Za Zhi. 2023 Nov 7;103(41):3294-3300. PubMed.

PAPER Chinese Society of Dementia and Cognitive lmpairment, Chinese Society of Nuclear Medicine

[Expert consensus on the application of amyloid-PET imaging in the diagnosis of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3615-3626. PubMed.

PAPER Xing Y, Qin Q, Wang ZB, Wang DY, Li SY, Sun YW, Jin HM, Wu GS, Cai LJ, Wang XY, Tang Y

[Observation of the consistency between intellectualized and manual-based cognitive assessment tools in the outpatient clinic].

Zhonghua Yi Xue Za Zhi. 2024 Feb 27;104(8):600-607. PubMed.

PAPER Zhang JW, Chen S

[The dilemma and comprehensive assessment for a precise diagnosis of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2024 Jul 30;104(29):2683-2687. PubMed.